Literature DB >> 23265615

Leishmania donovani zymodeme MON-37 isolated from an autochthonous visceral leishmaniasis patient in Sri Lanka.

Shalindra Ranasinghe1, Wen-Wei Zhang, Renu Wickremasinghe, Priyanka Abeygunasekera, Vishvanath Chandrasekharan, Sunethra Athauda, Suresh Mendis, Sanjeeva Hulangamuwa, Greg Matlashewski, Francine Pratlong.   

Abstract

Although the strain causing cutaneous leishmaniasis (CL) in Sri Lanka was first identified in 2003, the strain causing visceral leishmaniasis (VL) has not yet been identified. We report the first isoenzyme typing of a strain causing VL in Sri Lanka at an early stage of emergence of VL in the country. The parasite was isolated from a 57-year-old civil soldier who had been in the jungle in the Vavuniya district in the Northern Province of Sri Lanka for a period of nearly 6 months immediately before the onset of symptoms. Multilocus enzyme electrophoresis (MLEE) revealed that the strain is Leishmania donovani zymodeme MON-37, the zymodeme which was previously identified from the CL patients in the country. The MLEE analysis was confirmed by sequencing the gene encoding the 6-phosphogluconate dehydrogenase isoenzyme. This is an instance of the same Leishmania zymodeme associated with both dermotropism and viscerotropism in the same geographic region. Further investigations into the genetic structure and identification of virulence factors in the parasite and immune factors in the host are required to understand the factors responsible for different tropism shown by the same zymodeme MON-37 L. donovani from Sri Lanka.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23265615      PMCID: PMC4001626          DOI: 10.1179/2047773212Y.0000000054

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN: 2047-7724            Impact factor:   2.894


  17 in total

1.  Polymorphism among alleles of the 6-phosphogluconate dehydrogenase gene from Leishmania major and Leishmania tropica.

Authors:  Charles L Greenblatt; Lionel F Schnur; Gila Kahila Bar-Gal; Helen Ermolaev; Nir Peleg; Michael P Barrett
Journal:  Mol Biochem Parasitol       Date:  2002 Nov-Dec       Impact factor: 1.759

2.  First successful in vitro culture of Leishmania sp. causing autochthonous visceral leishmaniasis in Sri Lanka.

Authors:  P H K I S Ranasinghe; P H Abeygunasekera; S B Athauda; N V Chandrasekharan; A S V Mendis; C S Hulangamuwa; D R Wickremasinghe
Journal:  Ceylon Med J       Date:  2011-12

3.  Clinical and epidemiological studies on the cutaneous leishmaniasis caused by Leishmania (Leishmania) donovani in Sri Lanka.

Authors:  H V Y D Siriwardana; N Thalagala; N D Karunaweera
Journal:  Ann Trop Med Parasitol       Date:  2010-04

4.  The paraphyletic composition of Leishmania donovani zymodeme MON-37 revealed by multilocus microsatellite typing.

Authors:  Mohammad Zahangir Alam; Christos Haralambous; Katrin Kuhls; Evi Gouzelou; Dionyssios Sgouras; Ketty Soteriadou; Lionel Schnur; Francine Pratlong; Gabriele Schönian
Journal:  Microbes Infect       Date:  2009-04-17       Impact factor: 2.700

5.  Screening Leishmania donovani-specific genes required for visceral infection.

Authors:  Wen-Wei Zhang; Greg Matlashewski
Journal:  Mol Microbiol       Date:  2010-06-01       Impact factor: 3.501

6.  Multilocus microsatellite typing (MLMT) reveals genetic homogeneity of Leishmania donovani strains in the Indian subcontinent.

Authors:  Mohammad Zahangir Alam; Katrin Kuhls; Carola Schweynoch; Shyam Sundar; Suman Rijal; Abul Khair M Shamsuzzaman; Balaraju Venkata Subba Raju; Poonam Salotra; Jean-Claude Dujardin; Gabriele Schönian
Journal:  Infect Genet Evol       Date:  2008-10-08       Impact factor: 3.342

Review 7.  Is leishmaniasis in Sri Lanka benign and be ignored?

Authors:  N D Karunaweera; U S Rajapaksa
Journal:  J Vector Borne Dis       Date:  2009-03       Impact factor: 1.688

8.  Leishmania donovani causing cutaneous leishmaniasis in Sri Lanka: a wolf in sheep's clothing?

Authors:  Nadira D Karunaweera
Journal:  Trends Parasitol       Date:  2009-09-04

9.  Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy.

Authors:  Julius Lukes; Isabel L Mauricio; Gabriele Schönian; Jean-Claude Dujardin; Ketty Soteriadou; Jean-Pierre Dedet; Katrin Kuhls; K Wilber Quispe Tintaya; Milan Jirků; Eva Chocholová; Christos Haralambous; Francine Pratlong; Miroslav Oborník; Ales Horák; Francisco J Ayala; Michael A Miles
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-21       Impact factor: 11.205

10.  Leishmania donovani and cutaneous leishmaniasis, Sri Lanka.

Authors:  H V Yamuna D Siriwardana; Harry A Noyes; Nicholas J Beeching; Michael L Chance; Nadira D Karunaweera; Paul A Bates
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883

View more
  24 in total

1.  Emergence of visceral leishmaniasis in Sri Lanka: a newly established health threat.

Authors:  H V Y D Siriwardana; P Karunanayake; L Goonerathne; N D Karunaweera
Journal:  Pathog Glob Health       Date:  2017-08-18       Impact factor: 2.894

2.  Cutaneous Infection with Leishmania major Mediates Heterologous Protection against Visceral Infection with Leishmania infantum.

Authors:  Audrey Romano; Nicole A Doria; Jonatan Mendez; David L Sacks; Nathan C Peters
Journal:  J Immunol       Date:  2015-09-14       Impact factor: 5.422

3.  Use of a clinical tool for screening and diagnosis of cutaneous leishmaniasis in Sri Lanka.

Authors:  H V Y D Siriwardana; U Senarath; P H Chandrawansa; N D Karunaweera
Journal:  Pathog Glob Health       Date:  2015-07-16       Impact factor: 2.894

4.  In situ immunopathological changes in cutaneous leishmaniasis due to Leishmania donovani.

Authors:  N H Manamperi; S Oghumu; N Pathirana; M V C de Silva; W Abeyewickreme; A R Satoskar; N D Karunaweera
Journal:  Parasite Immunol       Date:  2017-03       Impact factor: 2.280

5.  Cross-sectional study to assess risk factors for leishmaniasis in an endemic region in Sri Lanka.

Authors:  Shalindra Ranasinghe; Rajitha Wickremasinghe; Asoka Munasinghe; Sanjeeva Hulangamuwa; Sundaramoorthy Sivanantharajah; Kamal Seneviratne; Samantha Bandara; Indira Athauda; Chaturi Navaratne; Ositha Silva; Hasini Wackwella; Greg Matlashewski; Renu Wickremasinghe
Journal:  Am J Trop Med Hyg       Date:  2013-08-05       Impact factor: 2.345

Review 6.  Leishmaniasis: where are we and where are we heading?

Authors:  Santanu Sasidharan; Prakash Saudagar
Journal:  Parasitol Res       Date:  2021-04-07       Impact factor: 2.289

7.  Genetic diversity of Leishmania donovani that causes cutaneous leishmaniasis in Sri Lanka: a cross sectional study with regional comparisons.

Authors:  Udeshika Lakmini Kariyawasam; Angamuthu Selvapandiyan; Keshav Rai; Tasaduq Hussain Wani; Kavita Ahuja; Mizra Adil Beg; Hasitha Upendra Premathilake; Narayan Raj Bhattarai; Yamuna Deepani Siriwardena; Daibin Zhong; Guofa Zhou; Suman Rijal; Hira Nakhasi; Nadira D Karunaweera
Journal:  BMC Infect Dis       Date:  2017-12-22       Impact factor: 3.090

8.  Characterisation of cutaneous leishmaniasis in Matara district, southern Sri Lanka: evidence for case clustering.

Authors:  K K G D U L Kariyawasam; C S Edirisuriya; U Senerath; D Hensmen; H V Y D Siriwardana; N D Karunaweera
Journal:  Pathog Glob Health       Date:  2015-09-07       Impact factor: 2.894

9.  Genetic analysis of Leishmania donovani tropism using a naturally attenuated cutaneous strain.

Authors:  Wen Wei Zhang; Gowthaman Ramasamy; Laura-Isobel McCall; Andrew Haydock; Shalindra Ranasinghe; Priyanka Abeygunasekara; Ganga Sirimanna; Renu Wickremasinghe; Peter Myler; Greg Matlashewski
Journal:  PLoS Pathog       Date:  2014-07-03       Impact factor: 6.823

10.  Polymerase chain reaction detection of Leishmania DNA in skin biopsy samples in Sri Lanka where the causative agent of cutaneous leishmaniasis is Leishmania donovani.

Authors:  Shalindra Ranasinghe; Renu Wickremasinghe; Sanjeeva Hulangamuwa; Ganga Sirimanna; Nandimithra Opathella; Rhaiza D C Maingon; Vishvanath Chandrasekharan
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-12-11       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.